(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
-0.53% HKD 9.30
Live Chart Being Loaded With Signals
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong...
Stats | |
---|---|
Tagesvolumen | 826 000 |
Durchschnittsvolumen | 772 223 |
Marktkapitalisierung | 7.03B |
EPS | HKD0 ( 2024-03-28 ) |
Last Dividend | HKD0.353 ( 2023-04-28 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 6.74 |
ATR14 | HKD0.0140 (0.15%) |
Volumen Korrelation
China Shineway Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
China Shineway Korrelation - Währung/Rohstoff
China Shineway Finanzdaten
Annual | 2023 |
Umsatz: | HKD4.52B |
Bruttogewinn: | HKD3.39B (75.15 %) |
EPS: | HKD1.280 |
FY | 2023 |
Umsatz: | HKD4.52B |
Bruttogewinn: | HKD3.39B (75.15 %) |
EPS: | HKD1.280 |
FY | 2022 |
Umsatz: | HKD3.95B |
Bruttogewinn: | HKD2.94B (74.38 %) |
EPS: | HKD0.960 |
FY | 2021 |
Umsatz: | HKD3.22B |
Bruttogewinn: | HKD2.41B (74.77 %) |
EPS: | HKD0.740 |
Financial Reports:
No articles found.
China Shineway Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.125 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.353 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.100 | 2005-09-01 |
Last Dividend | HKD0.353 | 2023-04-28 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 36 | -- |
Total Paid Out | HKD5.15 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.06 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.42 | |
Div. Directional Score | 8.98 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9869.HK | Ex Dividend Junior | 2023-09-19 | Insufficient data to determine frequency | 0 | 0.00% | |
2130.HK | Ex Dividend Knight | 2023-06-16 | Semi-Annually | 0 | 0.00% | |
1126.HK | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
0189.HK | Ex Dividend Junior | 2023-06-14 | Annually | 0 | 0.00% | |
3836.HK | Ex Dividend Junior | 2023-06-16 | Annually | 0 | 0.00% | |
1710.HK | Ex Dividend Junior | 2023-09-25 | Annually | 0 | 0.00% | |
0737.HK | Ex Dividend Knight | 2023-09-21 | Semi-Annually | 0 | 0.00% | |
2314.HK | Ex Dividend Junior | 2023-08-11 | Semi-Annually | 0 | 0.00% | |
1278.HK | Ex Dividend Junior | 2023-08-28 | Sporadic | 0 | 0.00% | |
0327.HK | Ex Dividend Knight | 2023-09-01 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.215 | 1.500 | 5.71 | 8.56 | [0 - 0.5] |
returnOnAssetsTTM | 0.101 | 1.200 | 6.62 | 7.95 | [0 - 0.3] |
returnOnEquityTTM | 0.142 | 1.500 | 9.54 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.327 | -1.000 | 6.73 | -6.73 | [0 - 1] |
currentRatioTTM | 3.35 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 2.95 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.42 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0315 | -1.500 | 9.48 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.229 | 2.00 | 9.59 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.039 | 2.00 | 9.48 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0428 | -1.500 | 9.83 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.751 | 1.000 | 0.809 | 0.809 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.215 | 1.000 | 7.70 | 7.70 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 3.10 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.472 | 0.800 | -0.188 | -0.151 | [0.5 - 2] |
Total Score | 11.55 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 6.74 | 1.000 | 9.42 | 0 | [1 - 100] |
returnOnEquityTTM | 0.142 | 2.50 | 9.70 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.039 | 2.00 | 9.65 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 6.72 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.229 | 2.00 | 9.59 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.327 | 1.500 | 6.73 | -6.73 | [0 - 1] |
pegRatioTTM | 0.245 | 1.500 | -1.701 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.206 | 1.000 | 7.34 | 0 | [0.1 - 0.5] |
Total Score | 6.42 |
China Shineway
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.